» Articles » PMID: 23578846

Biodegradable Microparticles for Strictly Regulating the Release of Neurotrophic Factors

Overview
Specialty Pharmacology
Date 2013 Apr 13
PMID 23578846
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A lot of research has been carried out in the last decade to find a cure for neurodegenerative diseases especially Parkinson's disease but to little avail. In this study we have demonstrated the use of poly(lactic-co-glycolic acid) (PLGA)/collagen biodegradable microparticles formed using water-in-oil-in-water (W/O/W) double emulsion method, as a neurotrophic factor delivery vehicle. The microparticles were encapsulated with glial cell-derived neurotrophic factor (GDNF) fused with collagen binding peptide (CBP) immobilized to the inner collagen phase. The novelty lies in the strict regulation of release of GDNF-CBP from the microparticles as compared to a burst release from standard microparticles. The microparticles were demonstrated to be non-cytotoxic till 300 μg/2 × 10⁵ cells and revealed a maximum release of 250 ng GDNF-CBP/mg microparticles in 0.3% collagenase. Differentiation of neural progenitor cells (NPCs) into mature neurons was demonstrated by co-culturing microparticles with cells in a medium containing collagenase which enabled the release of encapsulated GDNF-CBP, signaling the differentiation of NPCs into microtubule-associated protein 2 (MAP2)-expressing neurons. The successful ability of these microparticles to deliver neurotrophic factors and allow differentiation of NPCs into mature neurons provides some scope in its use for the treatment of Parkinson's disease and other neurodegenerative diseases.

Citing Articles

Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

De S, Banerjee S, Rakshit P, Banerjee S, Kumar S Curr Diabetes Rev. 2024; 21(6):32-58.

PMID: 38747222 DOI: 10.2174/0115733998291968240429111357.


Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems.

Paccione N, Rahmani M, Barcia E, Negro S Pharmaceutics. 2023; 15(1).

PMID: 36678642 PMC: 9866990. DOI: 10.3390/pharmaceutics15010013.


Injectables and Depots to Prolong Drug Action of Proteins and Peptides.

Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw P, Williams G Pharmaceutics. 2020; 12(10).

PMID: 33096803 PMC: 7589296. DOI: 10.3390/pharmaceutics12100999.


Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles.

Singh A, Biswas A, Shukla A, Maiti P Signal Transduct Target Ther. 2019; 4:33.

PMID: 31637012 PMC: 6799838. DOI: 10.1038/s41392-019-0068-3.